Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
Clinical trial NCT03938792 · COMPLETED
Trial details
- NCT number
- NCT03938792
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-09
- Primary completion
- 2025-04-29
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.